Global and United States Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2020-2026

    • ID: AR2972561
    • 06 October, 2020
    • Other
    • Region: Global
    • 99 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2026
      • 1.2.2 Synthetic Chemicals
      • 1.2.3 Biopharmaceuticals
      • 1.2.4 Others
    • 1.3 Market by Application
      • 1.3.1 Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2026
      • 1.3.2 Chronic & Autoimmune Diseases
      • 1.3.3 Oncology
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2015-2026)
    • 2.2 Global Biosimilar Monoclonal Antibody Growth Trends by Regions
      • 2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Biosimilar Monoclonal Antibody Historic Market Share by Regions (2015-2020)
      • 2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Biosimilar Monoclonal Antibody Players by Market Size
      • 3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2015-2020)
      • 3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2015-2020)
    • 3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
    • 3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
      • 3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2019
    • 3.5 Key Players Biosimilar Monoclonal Antibody Area Served
    • 3.6 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
    • 3.7 Date of Enter into Biosimilar Monoclonal Antibody Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Biosimilar Monoclonal Antibody Breakdown Data by Type (2015-2026)

    • 4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2015-2020)
    • 4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2021-2026)

    5 Biosimilar Monoclonal Antibody Breakdown Data by Application (2015-2026)

    • 5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2015-2020)
    • 5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Biosimilar Monoclonal Antibody Market Size (2015-2026)
    • 6.2 North America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
    • 6.3 North America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
    • 6.4 North America Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
      • 6.4.1 United States
      • 6.4.2 Canada

    7 Europe

    • 7.1 Europe Biosimilar Monoclonal Antibody Market Size (2015-2026)
    • 7.2 Europe Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
    • 7.3 Europe Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
    • 7.4 Europe Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
      • 7.4.1 Germany
      • 7.4.2 France
      • 7.4.3 U.K.
      • 7.4.4 Italy
      • 7.4.5 Russia
      • 7.4.6 Nordic
      • 7.4.7 Rest of Europe

    8 China

    • 8.1 China Biosimilar Monoclonal Antibody Market Size (2015-2026)
    • 8.2 China Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
    • 8.3 China Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
    • 8.4 China Biosimilar Monoclonal Antibody Market Size by Region (2015-2020)
      • 8.4.1 China
      • 8.4.2 Japan
      • 8.4.3 South Korea
      • 8.4.4 Southeast Asia
      • 8.4.5 India
      • 8.4.6 Australia
      • 8.4.7 Rest of Asia-Pacific

    9 Japan

    • 9.1 Japan Biosimilar Monoclonal Antibody Market Size (2015-2026)
    • 9.2 Japan Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
    • 9.3 Japan Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
    • 9.4 Japan Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
      • 9.4.1 Mexico
      • 9.4.2 Brazil

    10 Southeast Asia

    • 10.1 Southeast Asia Biosimilar Monoclonal Antibody Market Size (2015-2026)
    • 10.2 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
    • 10.3 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
    • 10.4 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
      • 10.4.1 Turkey
      • 10.4.2 Saudi Arabia
      • 10.4.3 UAE
      • 10.4.4 Rest of Middle East & Africa

    11 Key Players Profiles

    • 11.1 Biocon
      • 11.1.1 Biocon Company Details
      • 11.1.2 Biocon Business Overview
      • 11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
      • 11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2015-2020))
      • 11.1.5 Biocon Recent Development
    • 11.2 Accord Healthcare
      • 11.2.1 Accord Healthcare Company Details
      • 11.2.2 Accord Healthcare Business Overview
      • 11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
      • 11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.2.5 Accord Healthcare Recent Development
    • 11.3 AET Biotech
      • 11.3.1 AET Biotech Company Details
      • 11.3.2 AET Biotech Business Overview
      • 11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
      • 11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.3.5 AET Biotech Recent Development
    • 11.4 Amgen
      • 11.4.1 Amgen Company Details
      • 11.4.2 Amgen Business Overview
      • 11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
      • 11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.4.5 Amgen Recent Development
    • 11.5 Celltrion
      • 11.5.1 Celltrion Company Details
      • 11.5.2 Celltrion Business Overview
      • 11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
      • 11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.5.5 Celltrion Recent Development
    • 11.6 Reddy's Laboratories
      • 11.6.1 Reddy's Laboratories Company Details
      • 11.6.2 Reddy's Laboratories Business Overview
      • 11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
      • 11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.6.5 Reddy's Laboratories Recent Development
    • 11.7 Hospira
      • 11.7.1 Hospira Company Details
      • 11.7.2 Hospira Business Overview
      • 11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
      • 11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.7.5 Hospira Recent Development
    • 11.8 3SBio
      • 11.8.1 3SBio Company Details
      • 11.8.2 3SBio Business Overview
      • 11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
      • 11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.8.5 3SBio Recent Development
    • 11.9 Allergan
      • 11.9.1 Allergan Company Details
      • 11.9.2 Allergan Business Overview
      • 11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
      • 11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.9.5 Allergan Recent Development
    • 11.10 Alvartis
      • 11.10.1 Alvartis Company Details
      • 11.10.2 Alvartis Business Overview
      • 11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
      • 11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
      • 11.10.5 Alvartis Recent Development

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Disclaimer

      Global Biosimilar Monoclonal Antibody Scope and Market Size
      Biosimilar Monoclonal Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      Market segment by Type, the product can be split into
      Synthetic Chemicals
      Biopharmaceuticals
      Others

      Market segment by Application, split into
      Chronic & Autoimmune Diseases
      Oncology
      Others

      Based on regional and country-level analysis, the Biosimilar Monoclonal Antibody market has been segmented as follows:
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Nordic
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia-Pacific
      Latin America
      Mexico
      Brazil
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of Middle East & Africa

      In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilar Monoclonal Antibody market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
      The key players covered in this study
      Biocon
      Accord Healthcare
      AET Biotech
      Amgen
      Celltrion
      Reddy's Laboratories
      Hospira
      3SBio
      Allergan
      Alvartis



      Summary:
      Biosimilar Monoclonal Antibody Market Research Report is about Biosimilar Monoclonal Antibody Industry study. Get complete Biosimilar Monoclonal Antibody market research report published after Market Study, Industrial Analysis with Trends & Statistics. Biosimilar Monoclonal Antibody Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED